Enterohormonal Changes After Digestive Adaptation: Five-Year Results of a Surgical Proposal to Treat Obesity and Associated Diseases
Authors:
- 15 December 2007
- journal article
- Published by Springer Nature in Obesity Surgery
- Vol. 18 (1) , 17-26
Abstract
Recent physiological knowledge allows the design of bariatric procedures that aim at neuroendocrine changes instead of at restriction and malabsorption. Digestive adaptation is a surgical technique for obesity based in this rationale. The technique includes a sleeve gastrectomy, an omentectomy and a jejunectomy that leaves initial jejunum and small bowel totaling at least 3 m (still within normal variation of adult human bowel length). Fasting ghrelin and resistin and fasting and postprandial GLP-1 and PYY were measured pre- and postoperatively. Patients: 228 patients with initial body mass index (BMI) varying from 35 to 51 kg/m2; follow-up: 1 to 5 years; average EBMIL% was 79.7% in the first year; 77.7% in the second year; 71.6% in the third year; 68.9% in the fourth year. Patients present early satiety and major improvement in presurgical comorbidities, especially diabetes. Fasting ghrelin and resistin were significantly reduced (P < 0.05); GLP-1 and PYY response to food ingestion was enhanced (P < 0.05). Surgical complications (4.4%) were resolved without sequela and without mortality. There was neither diarrhea nor detected malabsorption. Based on physiological and supported by evolutionary data, this procedure creates a proportionally reduced gastrointestinal (GI) tract that amplifies postprandial neuroendocrine responses. It leaves basic GI functions unharmed. It reduces production of ghrelin and resistin and takes more nutrients to be absorbed distally enhancing GLP-1 and PYY secretion. Diabetes was improved significantly without duodenal exclusion. The patients do not present symptoms nor need nutritional support or drug medication because of the procedure, which is safe to perform.Keywords
This publication has 33 references indexed in Scilit:
- Laparoscopic sleeve gastrectomy with ileal interposition (“neuroendocrine brake”)—pilot study of a new operationSurgery for Obesity and Related Diseases, 2006
- Is all fat the same? The role of fat in the pathogenesis of the metabolic syndrome and type 2 diabetes mellitusSurgery, 2006
- Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic ParametersAnnals of Surgery, 2006
- Obesity-Associated HypertensionHypertension, 2005
- Slowing intestinal transit by PYY depends on serotonergic and opioid pathwaysAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2004
- Evidence for Early Impairment of Glucagon-Like Peptide 1-Induced Insulin Secretion in Human Type 2 (Non Insulin-Dependent) DiabetesHormone and Metabolic Research, 2002
- Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin.Journal of Clinical Investigation, 1998
- Attenuated GLP-1 secretion in obesity: cause or consequence?Gut, 1996
- Evolutionary perspectives on human nutrition: The influence of brain and body size on diet and metabolismAmerican Journal of Human Biology, 1994
- GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MANThe Lancet, 1987